Literature DB >> 544571

Whole abdominal irradiation by a moving-strip technique for patients with ovarian cancer.

A J Dembo, J Van Dyk, B Japp, H A Bean, F A Beale, J F Pringle, R S Bush.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 544571     DOI： 10.1016/0360-3016(79)90942-8

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN： 0360-3016            Impact factor:   7.038


× No keyword cloud information.
  7 in total

1.  Whole-abdomen radiation in patients with advanced ovarian carcinoma after surgery, chemotherapy, and second-look laparotomy.

Authors:  R Greiner; A Goldhirsch; B W Davis; E Dreher; T Peyer; G Locher; H Neuenschwander; R Joss; K Brunner; P Veraguth
Journal:  J Cancer Res Clin Oncol       Date:  1984       Impact factor: 4.553

2.  Postoperative abdominopelvic irradiation in patients with epithelial cancer of ovary. The Princess Margaret Hospital Experience.

Authors:  A J Dembo
Journal:  J Cancer Res Clin Oncol       Date:  1984       Impact factor: 4.553

Review 3.  The efficacy of conventional external beam, three-dimensional conformal, intensity-modulated, particle beam radiation, and brachytherapy for localized prostate cancer.

Authors:  Tony Y Eng; Join Y Luh; Charles R Thomas
Journal:  Curr Urol Rep       Date:  2005-05       Impact factor: 3.092

4.  Second annual meeting of the Association of Cancer Physicians (in conjunction with the 28th AGM of the British Association for Cancer Research). April 6-8, 1987, Newcastle-upon-Tyne, UK. Abstracts.

Authors: 
Journal:  Br J Cancer       Date:  1987-08       Impact factor: 7.640

5.  The British Association for Cancer Research, 23rd annual general meeting. Edinburgh 29--31 March 1982. Abstracts.

Authors: 
Journal:  Br J Cancer       Date:  1982-09       Impact factor: 7.640

6.  Protocol allocation and exclusion in two Danish randomised trials in ovarian cancer.

Authors:  K Bertelsen
Journal:  Br J Cancer       Date:  1991-12       Impact factor: 7.640

7.  Long-term follow-up of patients with advanced ovarian cancer treated in randomised clinical trials.

Authors:  J Warwick; S Kehoe; H Earl; D Luesley; C Redman; K K Chan
Journal:  Br J Cancer       Date:  1995-12       Impact factor: 7.640
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.